Perrigo Reaches $1.5bn Deal With Altaris For Rx Business
Company Announces Divestment After Holding Out For The Right Valuation
Perrigo has finally found the right deal to secure the long-awaited divestment of its prescription business, reaching an agreement worth just over $1.5bn with private equity firm Altaris Capital Partners.
